Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes comparable with patients receiving ...

PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first ...

WASHINGTON, DC—Use of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) appears to be a safe and effective option for the treatment of in-stent restenosis, but acute and late ...

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...

Two new meta-analyses evaluating the safety and effectiveness of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) suggest the “dissolving” stent is as safe and effective as an ...

On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...

The independent panel of experts convened by FDA decided that the benefits of Abbott's Absorb bioresorbable drug eluting coronary stent outweigh the risks. Nancy Crotti An FDA advisory committee has ...

CHICAGO, IL — Due to low commercial sales, Abbott will stop selling the first-generation bioresorbable Absorb coronary stent, the company announced [1]. Abbott will discontinue all sizes of Absorb ...

Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's widely used Xience drug ...

WASHINGTON (March 18, 2017) -- Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes ...